Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 826 across all filing types
Latest filing 2019-07-22 Interim / Quarterly Rep…
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Rapport semestriel 2019
Interim / Quarterly Report Classification · 1% confidence The document is a 'Rapport Semestriel d'Activité' (Half-Year Activity Report) for Adocia, covering the period ending June 30, 2019. It contains detailed financial statements, management discussion and analysis (MDA), and an audit report summary. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. H1 2019
2019-07-22 French
Inside Information / News release on accounts, results
Interim / Quarterly Report Classification · 1% confidence The document is a press release titled 'Adocia Presents First Half 2019 Financial Results'. It contains condensed consolidated interim financial statements, including a balance sheet summary and income statement data for the six-month period ended June 30, 2019. It provides a detailed management discussion and analysis of the financial performance, operational highlights, and clinical trial updates. Since it contains substantive financial data and analysis for an interim period (half-year), it is classified as an Interim/Quarterly Report (IR). H1 2019
2019-07-17 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and explicitly announces "Adocia annonce ses résultats financiers pour le premier semestre 2019" (Adocia announces its financial results for the first half of 2019). It contains synthetic financial data (table comparing H1 2019 vs H1 2018) and management commentary on the period's performance. This structure—a brief announcement highlighting key figures for a specific interim period (six months)—perfectly matches the definition of an Earnings Release (ER). While it contains interim financial data, the format is a press release summarizing results, not the comprehensive, formal 'Interim Report' (IR) which would typically be a much longer regulatory filing. H1 2019
2019-07-17 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and reports on the semi-annual balance of a liquidity contract (contrat de liquidité) with Kepler Capital Markets as of June 30, 2019, comparing it to the previous report from December 31, 2018. This type of announcement, detailing specific financial arrangements or operational updates outside of standard periodic financial reports (like 10-K or IR), often falls under general regulatory announcements or specific corporate actions. Since it is a press release providing specific, non-periodic financial/contractual information (liquidity contract status), and it is not a full earnings release (ER), a capital change (CAP/SHA), or a director dealing (DIRS), it best fits the general regulatory announcement category, which is RNS, or potentially a specific update if one existed. Given the options, RNS (Regulatory Filings) is the most appropriate fallback for a specific, non-standard corporate announcement like this liquidity report, as it is a formal communication to the market. However, upon reviewing the definitions, the content is a specific update on a financial arrangement (liquidity contract) and is presented as a press release. It is not a standard quarterly/annual report, an earnings release, or a management discussion. It is a specific disclosure. If we consider the nature of the disclosure—a report on the status of a liquidity agreement—it is a specific corporate disclosure. Since there is no specific code for 'Liquidity Contract Status Update', RNS (Regulatory Filings) serves as the best general category for formal, non-standard market disclosures.
2019-07-11 French
Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Capital/Financing Update Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and discusses a specific financial update: the "Half year report on Adocia's liquidity agreement with Kepler Capital Markets" as of June 30, 2019, comparing it to the previous period (December 31, 2018). This is a periodic announcement providing key financial/operational data outside of a full annual or quarterly report structure. Since it is a press release announcing specific periodic financial data (liquidity figures) and is not a full comprehensive report (like 10-K or IR), it fits best as an Earnings Release (ER) which covers initial announcements of periodical results, or potentially a Regulatory Filing (RNS) if it were less specific. Given the focus on half-year liquidity figures, it aligns closely with the scope of an ER, which often includes key highlights preceding a full interim report. However, because it is specifically about a liquidity agreement update and not the core operational/P&L results typically associated with an ER, and it is a short press release format, it could also be considered a general Regulatory Filing (RNS). Comparing the options, 'ER' is for initial announcements of periodical financial results (key highlights only). This document provides key highlights (liquidity figures) for the half-year period. If a dedicated 'Interim Report' (IR) exists, this press release acts as the preliminary announcement. Given the structure and content (press release format, specific financial update for a period), ER is the most appropriate fit among the specific financial announcement codes.
2019-07-11 English
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and its primary content is the announcement of the "Number of shares and voting rights of ADOCIA as of June 30, 2019." This type of periodic disclosure, mandated by French financial regulations (AMF), reports specific, non-financial operational data (share count and voting rights) rather than comprehensive financial results (like an ER or IR) or management changes (MANG). While it is a regulatory disclosure, the specific nature of reporting outstanding shares and voting rights aligns closely with the requirements often associated with general regulatory updates or specific shareholder/capital structure notifications. Since there is no specific code for 'Share Capital/Voting Rights Disclosure,' and it is not a full financial report (10-K, IR), nor a management discussion (MDA), nor a director dealing report (DIRS), it falls best under the general regulatory announcement category, RNS, as it is a mandatory, periodic filing of specific corporate data required by the regulator (AMF). It is not an announcement *about* a report (RPA), but the report itself.
2019-07-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.